These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8852082)

  • 1. [Evaluation of the costs of mammographic screening program in the city of Florence].
    Spagnolo G; Zappa M; Paci E; Giorgi D; Rosselli del Turco M
    Epidemiol Prev; 1995 Dec; 19(65):330-7. PubMed ID: 8852082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost analysis of a mammographic screening program].
    Vanara F; Ponti A; Frigerio A; Segnan N
    Epidemiol Prev; 1995 Dec; 19(65):318-29. PubMed ID: 8852081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
    Menon A; Devlin NJ; Richardson AK
    N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An academic health center cost analysis of screening mammography: creating a financially viable service.
    Chen SL; Clark S; Pierce LJ; Hayes DF; Helvie MA; Greeno PL; Newman LA; Chang AE
    Cancer; 2004 Sep; 101(5):1043-50. PubMed ID: 15329914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
    Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A workplace breast cancer screening program. Costs and components.
    Schrammel P; Griffiths RI; Griffiths CB
    AAOHN J; 1998 Nov; 46(11):523-9. PubMed ID: 9934000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
    Olivotto IA; Kan L; Mates D; King S
    CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second reading of screening mammograms increases cancer detection and recall rates. Results in the Florence screening programme.
    Ciatto S; Ambrogetti D; Bonardi R; Catarzi S; Risso G; Rosselli Del Turco M; Mantellini P
    J Med Screen; 2005; 12(2):103-6. PubMed ID: 15949122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for breast cancer in England: past and future.
    Advisory Committee on Breast Cancer Screening
    J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and mammographic screening in a district of Milan: organization, social influence and results].
    Pravettoni A; Cescon S; Moro G; Verga M; Saibene F; Micheli A
    Epidemiol Prev; 1993 Dec; 17(57):296-301. PubMed ID: 7957707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of tandem mass spectrometry screening in California.
    Feuchtbaum L; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of the costs in two mammographic screening programmes in the province of Florence, Italy.
    Zappa M; Spagnolo G; Ciatto S; Giorgi D; Paci E; Rosseli del Turco M
    J Med Screen; 1995; 2(4):191-4. PubMed ID: 8719147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness of mammography screening in Norway].
    Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2003 Australian Breast Health Survey: survey design and preliminary results.
    Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H
    BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic analysis of outreach assessment clinics in breast screening programmes.
    van der Pol MM; Cairns JA; Gilbert FJ; Hendry PJ
    Int J Health Plann Manage; 1999; 14(1):57-67. PubMed ID: 10351680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.